Oxyntomodulin vs Cotadutide

Head-to-head comparison of Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) and Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOxyntomodulinCotadutide
CategoryWeight ManagementWeight Management
Full NameEndogenous glucagon-like peptide 1 and glucagon co-agonist peptideMEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Molecular Weight~4,200 Da~4,700 Da
Half-Life12-15 minutesApproximately 24 hours
Amino Acids3737
Typical DoseResearch doses vary; commonly 100-300 mcg in small human studies0.3-3 mg daily in clinical studies
RouteSubcutaneous/IVSubcutaneous
Purity≥98%≥98%
Studies Count8018
Research StatusClinicalClinical

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Oxyntomodulin stacks with:

calorie-deficitresistance-training

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program
GLP-1glucagon-coagonistendogenous-peptideappetite-regulationdual-agonistobesity-research